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Statin lipid-lowering drugs have been shown to induce muscular stress conditions and
increase incidence of myopathy, especially in exercising individuals. RhoA, a GTPase
involved in muscle repair and intracellular damage signaling, adapts both acutely
(increased activation) and chronically (increased protein expression) to muscular stress
conditions. Statins inhibit production of mevalonate, upstream of geranylgeranyl
pyrophosphate (GGPP), which anchors newly translated RhoA to the cell membrane.
This inhibition may suppress the ability to chronically increase RhoA expression.
Purpose: To determine if exercise and statin treatment elicit different RhoA adaptations
to muscular stress conditions. Methods: Mice were randomized into vehicle (Veh)
control, one of three simvastatin doses (60, 200, or 400 mg · kg-1), or Veh plus intense
eccentric exercise (Veh+EX). After two weeks, tibialis anterior muscle was harvested and
analyzed via western blot for RhoA activity (percentage activated) and total RhoA
expression. Results: Both the Veh+EX and all statin groups had elevated RhoA activity
(p<0.05). RhoA expression increased in the Veh+EX group (p<0.01), but was unchanged
between Veh and statin groups. There were no significant differences between statin
doses. Conclusion: The increased RhoA activity with statin treatment and exercise
shows a similar acute adaptation to stress, but the expected increase in RhoA expression
was suppressed by all doses of simvastatin. This may play a role in the increased
myopathy rate observed in exercising statin users. Future study should investigate if other
signaling proteins modified by GGPP are also affected.
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